Skip to Main Content

Advertisement

Issue Archive

Table of Contents

EXCEPTIONAL CASE REPORTS

CLINICAL TRIALS AND OBSERVATIONS

HEMATOPOIESIS AND STEM CELLS

IMMUNOBIOLOGY

LYMPHOID NEOPLASIA

MYELOID NEOPLASIA

RED CELLS, IRON, AND ERYTHROPOIESIS

THROMBOSIS AND HEMOSTASIS

TRANSFUSION MEDICINE

TRANSPLANTATION

COMMENTARIES

  • Cover Image

    Cover Image

    issue cover

    COVER FIGURE
    Model of evolution from clonal hematopoiesis of indeterminate potential (CHIP) to therapy-related myeloid neoplasms. A CHIP clone with a DNMT3A mutation acquired deletion 7, and then 2 subclones acquired a PTPN11 mutation and trisomy 22, an NRAS mutation. See the article by Takahashi et al.

  • PDF Icon PDF LinkFront Matter
  • PDF Icon PDF LinkEditorial Board
Close Modal
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close Modal
Close Modal

Advertisement